Medicine Consents




2312

NEW ZEALAND GAZETTE

No. 85

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Dimetapp Cold & Flu Night Relief Liquid Caps

Active Ingredients: Dextromethorphan hydrobromide 10mg
Doxylamine succinate 6.25mg
Paracetamol 300mg
Pseudoephedrine hydrochloride 30mg

Dosage Form: Liquid filled capsule

New Zealand Sponsor: Whitehall Consumer Healthcare (NZ) Limited

Manufacturer: R P Scherer Holdings Pty Limited, Braeside, Victoria, Australia

Product: Exelon

Active Ingredient: Rivastigmine tartrate 3.2mg/mL equivalent to 2mg/mL rivastigmine base

Dosage Form: Oral solution

New Zealand Sponsor: Novartis New Zealand Limited

Manufacturer: Famar France, Orleans Cedex, France

Product: Rogaine (Women’s)

Active Ingredient: Minoxidil 20mg/mL

Dosage Form: Topical solution

New Zealand Sponsor: Pharmacia Limited Company (trading as Pharmacia)

Manufacturers: Pharmacia NV/SA, Puurs, Belgium
Pharmacia, Kalamazoo, Michigan, United States of America

Dated this 18th day of July 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go4885

Renewal of Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Conthram Forte

Active Ingredients: Danthron 15mg/mL
Poloxamer 188 200mg/mL

Dosage Form: Oral suspension

New Zealand Sponsor: Pacific Pharmaceuticals Limited

Manufacturer: Pacific Pharmaceuticals Limited, Mt Wellington, Auckland

This consent is given subject to the following conditions:

● This medicine may only be used for the prevention of constipation in the terminally ill.

Note: This consent is valid for two years from the 19 October 2002.

Product: Conthram

Active Ingredients: Danthron 5mg/mL
Poloxamer 188 40mg/mL

Dosage Form: Oral suspension

New Zealand Sponsor: Pacific Pharmaceuticals Limited

Manufacturer: Pacific Pharmaceuticals Limited, Mt Wellington, Auckland

This consent is given subject to the following conditions:

● This medicine may only be used for the prevention of constipation in the terminally ill.

Note: This consent is valid for two years from 19 October 2002.

Product: Pentaspan

Active Ingredient: Poly-O-(2-hydroxyethyl)-starch 100mg/mL

Dosage Form: Solution for infusion

New Zealand Sponsor: Boots Healthcare Medical N Z Div. Boots Healthcare Australia

Manufacturer: NPBI BV, Runde, Emmer-Compascuum, The Netherlands

Note: This consent is valid for two years from 20 April 2002.



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 85


Gazette.govt.nz PDF NZ Gazette 2002, No 85





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
18 July 2002
Medicines Act, New medicines, Distribution consent
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Renewal of Provisional Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines Act, Provisional consent, Renewal